Clinical Trial Update: Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating Gemcitabine, Vincristine, and Cisplatin as a second-line therapy for sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Vincristine (vincristine)

Snippet

Sponsor: Fudan University | Conditions: Sarcoma, Chemotherapy | Phase 2 | Status: UNKNOWN